Holen Sie sich die Stockscreener-App
161.98
1.47%
-2.42
Handel nachbörslich:
161.65
-0.33
-0.20%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$164.40
Offen:
$163.35
24-Stunden-Volumen:
3.13M
Relative Volume:
1.34
Marktkapitalisierung:
$36.54B
Einnahmen:
$222.29B
Nettoeinkommen (Verlust:
$1.56B
KGV:
25.27
EPS:
6.41
Netto-Cashflow:
$2.44B
1W Leistung:
-1.08%
1M Leistung:
+4.33%
6M Leistung:
+37.25%
1J Leistung:
+67.79%
1-Tages-Spanne:
$161.65
$164.25
1-Wochen-Bereich:
$161.65
$168.44
52-Wochen-Spanne:
$93.17
$168.44
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Vergleichen Sie CAH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
161.98 | 36.54B | 222.29B | 1.56B | 2.44B | 6.41 |
|
MCK
Mckesson Corporation
|
705.45 | 88.11B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
291.17 | 55.56B | 310.23B | 1.69B | 3.58B | 8.62 |
|
HSIC
Henry Schein Inc
|
74.48 | 8.92B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
9.29 | 623.64M | 10.42B | -38.77M | 323.54M | -0.51 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health raises FY 2025 EPS guidance to $8.05-$8.15 amid strong pharma growth and acquisitions - MSN
Cardinal Health (CAH) Affirms Long-Term Growth Raises Outlook - MSN
Deutsche Bank Adjusts Cardinal Health Price Target to $163 From $148 - MarketScreener
Deutsche Bank Raises Price Target on Cardinal Health to $163 From $148, Keeps Hold Rating - marketscreener.com
Cardinal Health (NYSE:CAH) Eyes EPS Growth With IRA Momentum S&P 500 - Kalkine Media
Medical Commode Market Key Players Analysis -Medline - openPR.com
Cardinal Health raises FY25 earnings outlook on investor day - MSN
Cardinal Health (NYSE:CAH) Targets Double-Digit EPS Growth Amid IRA Tailwinds and Healthcare Sector Strength - MSN
Cardinal Health Raises Pharmaceutical Segment Profit Guidance 12-13% for FY25 - cheddar.com
How Is Cardinal Health’s Stock Performance Compared to Other Health Care Service Stocks? - The Globe and Mail
Jefferies Adjusts Price Target on Cardinal Health to $190 From $170, Maintains Buy Rating - marketscreener.com
12 Best Healthcare Stocks to Buy Now - Insider Monkey
TD Cowen Affirms Buy Rating on Cardinal Health - Yahoo Finance
Cardinal Health (CAH) Sees Increased Price Target to $182 by Argus | CAH Stock News - GuruFocus
Cardinal Health price target raised to $185 from $170 at UBS - Investing.com
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Cardinal Health Insiders Sell US$18m Of Stock, Possibly Signalling Caution - Yahoo
Cardinal Health (CAH) Sees Price Target Raised by Morgan Stanley - GuruFocus
Cardinal Health (CAH) Price Target Raised by Citigroup Analyst | CAH Stock News - GuruFocus
Cardinal Health Lifts Earnings Outlook, Impressing Wall Street - Finimize
Cardinal Health (CAH) Sees Price Target Uplift Amid Positive Ind - GuruFocus
Cardinal Health's Guidance Reflects 'Durable Favorable' Backdrop in Drug Distribution Industry, Morgan Stanley Says - marketscreener.com
Cardinal Health (CAH) Receives Upgraded Price Target from BofA A - GuruFocus
Cardinal Health Optimizes Strategy As Earnings Projection Looks Bright - Finimize
Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Finance
Cardinal Health Likely Seeing 'More Durable Favorable' Environment as Fiscal 2025 Guidance Raised, Morgan Stanley Says - marketscreener.com
Citius Oncology enters distribution services agreement with Cardinal Health - MSN
Cardinal Health (CAH) Receives Upgraded Price Target from BofA Analyst | CAH Stock News - GuruFocus
Cardinal Health (CAH) Price Target Raised to $170 by Citi Analyst | CAH Stock News - GuruFocus
Incontinence Pads Market Top PlayersCardinal Health Inc., - openPR.com
Evercore ISI Increases Cardinal Health (CAH) Price Target to $18 - GuruFocus
Cardinal Health (CAH) Target Price Raised to $180 by Evercore IS - GuruFocus
US Market Gains As Oracle And Cardinal Health Shine - Finimize
Cardinal Health Inc (CAH) Trading 3.77% Higher on Jun 12 - GuruFocus
Cardinal Health: Strong Outlook and Growing Priorities on Specialty Headline Solid Investor Day - Morningstar
Cardinal Health (CAH) Sets Ambitious Long-Term Growth Targets | - GuruFocus
Cardinal Health boosts profit view banking on specialty drugs unit growth - Reuters
Cardinal Health: Investor Day Highlights Solid Distribution Trend and Strong Long-Term Targets - Morningstar
Cardinal Health (CAH) Updates Fiscal Year 2025 Outlook and Provi - GuruFocus
Cardinal Health (CAH) Adjusts Fiscal Projections and Strategic P - GuruFocus
Transcript : Cardinal Health, Inc.Analyst/Investor Day - MarketScreener
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Chime debut, ConAgra downgrade, Cardinal Health lifts outlook - Yahoo Finance
Cardinal Health (CAH) Target Price Raised to $180 by Evercore ISI | CAH Stock News - GuruFocus
Cardinal Health Lifts Earnings Guidance Amid Strong Growth Outlook - Finimize
Cardinal Health (CAH) Pursues Growth through Strategic Investmen - GuruFocus
Cardinal Health stock soars to all-time high of $158.1 By Investing.com - Investing.com Nigeria
Cardinal Health stock soars to all-time high of $158.1 - Investing.com
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cardinal Health Inc-Aktie (CAH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mayer Jessica L | Chief Legal/Compliance Officer |
Aug 21 '24 |
Sale |
109.39 |
16,573 |
1,812,920 |
75,971 |
1.41%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):